Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier

Several large population-based or clinical trial studies have suggested that certain dihydropyridine (DHP) L-type calcium channel blockers (CCBs) used for the treatment of hypertension may confer protection against the development of Alzheimer disease (AD). However, other studies with drugs of the s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Paris, Daniel, Bachmeier, Corbin, Patel, Nikunj, Quadros, Amita, Volmar, Claude-Henry, Laporte, Vincent, Ganey, Jim, Beaulieu-Abdelahad, David, Ait-Ghezala, Ghania, Crawford, Fiona, Mullan, Michael J
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: ScholarOne 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3060987/
https://ncbi.nlm.nih.gov/pubmed/21170472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2010.00180
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg